Eczacıbaşı-Monrol Nuclear Products, an equal share joint venture between Monrol Nuclear Products Inc. and Eczacıbaşı Pharmaceuticals Manufacturing that was established in 2008, leads the development of Turkey’s nuclear medicine market through the production of high-quality radiopharmaceuticals for diagnosis and treatment.